Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription Articles published in Neurochem Res Retrieve available abstracts of 42 articles: HTML format

Single Articles

December 2025
1. ZHOU H, Fan H, Bian H, Zou Y, et al
   PRMT5 Aggravates Parkinson's Disease Progression Through the Inhibition of Neuronal Autophagy Through DKK1.
   Neurochem Res. 2025;51:12.
   PubMed     Abstract available
   
   
   November 2025
2. HAN B, Bai J
   Mitochondrial Calcium Channels and MAM Interaction in Calcium Homeostasis Dysregulation in Parkinson's Disease.
   Neurochem Res. 2025;50:361.
   PubMed     Abstract available
   
   
   
3. EVINOVA A, Okruhlica I, Racay P, Strnadel J, et al
   Intracellular Calcium Changes Correlate with Mitochondrial Dynamics After Differential Modulation of KATP Channels in a Cellular Model of Parkinson's Disease.
   Neurochem Res. 2025;50:345.
   PubMed     Abstract available
   
   
   October 2025
4. MANCA E, Corsi S, Fanni S, Noli B, et al
   Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.
   Neurochem Res. 2025;50:344.
   PubMed     Abstract available
   
   
   
5. PENSABENE D, Martella N, Scavo G, Bisesto E, et al
   p75NTR Modulation by LM11A-31 Counteracts Oxidative Stress and Cholesterol Dysmetabolism in a Rotenone-Induced Cell Model of Parkinson's Disease.
   Neurochem Res. 2025;50:315.
   PubMed     Abstract available
   
   
   
6. WALECHA V, Luthra PM
   The Mitochondrial-Astrocyte-Neuron Triad Hypothesis in Parkinson's Disease: A Toxic Feedback Loop of Metabolism, Aggregation, and Oxidative Stress.
   Neurochem Res. 2025;50:317.
   PubMed     Abstract available
   
   
   September 2025
7. WANKHEDE M, Rathod K, Aswar M, Aswar U, et al
   Stigmasterol Alleviates Levodopa-Induced Dyskinesia in 6-OHDA-Induced Parkinsonian Rats.
   Neurochem Res. 2025;50:304.
   PubMed     Abstract available
   
   
   
8. ZHU L, Lin L, Yang Z, Tang H, et al
   Sinomenine Modifies Parkinson's Disease Through Nrf2 Activation.
   Neurochem Res. 2025;50:302.
   PubMed     Abstract available
   
   
   
9. MEKHLOUF YE, Bouhaddou N, Dimaoui A, Ittorahou A, et al
   Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.
   Neurochem Res. 2025;50:294.
   PubMed     Abstract available
   
   
   August 2025
10. DESHPANDE V, Schick K, Mazumder P, Dutta AK, et al
    Biological Characterization of the Anti-ferroptotic Properties of a Novel Anti-Parkinsonian Iron (II) Selective Dopamine Agonist, D-583.
    Neurochem Res. 2025;50:264.
    PubMed     Abstract available
    
    
    June 2025
11. CHEN P, Yang J, Xu Y, Chen J, et al
    MicroRNA-361-3p Regulates Autophagy and Apoptotic Processes by Regulating PI3K/Akt Signaling in Parkinson's Disease.
    Neurochem Res. 2025;50:221.
    PubMed     Abstract available
    
    
    
12. ABD EL-KHALIK SR, AbuoHashish NA, Nasif E, Arakeep HM, et al
    Possible Mitigating Effect of Nobiletin on Rotenone-Induced Parkinsonism in Male Albino Rat Model: Targeting Bmal1/Nrf2 Mediated Ferroptosis and Restoring Mitochondrial Mitophagy.
    Neurochem Res. 2025;50:208.
    PubMed     Abstract available
    
    
    May 2025
13. NI Y, Hayat MA, Si Y, Guo T, et al
    Protective Effect of FABP5 Against 6-OHDA Induced Parkinson's Disease Via PPARgamma/SIRT1/PGC-1alpha Signaling Pathway.
    Neurochem Res. 2025;50:177.
    PubMed     Abstract available
    
    
    
14. CHINNAPPAN D, Krishnan M, Kuppamuthu A, Elangovan N, et al
    Developmental and Neuroprotective Effects of alpha-Terpineol in MPTP-Induced Parkinsonism in Zebrafish Larvae.
    Neurochem Res. 2025;50:158.
    PubMed     Abstract available
    
    
    April 2025
15. LEE C, Kim SS, Bae MA, Kim SH, et al
    Neuroprotective Activities of Sertraline, Tiagabine, and Bicifadine with Autophagy-Inducing Potentials in a 6-Hydroxidopamine-Treated Parkinson's Disease Cell Model.
    Neurochem Res. 2025;50:154.
    PubMed     Abstract available
    
    
    
16. SAHOO TA, Chand J, Kandy AT, Antony S, et al
    Unravelling the Proteinopathic Engagement of alpha-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.
    Neurochem Res. 2025;50:145.
    PubMed     Abstract available
    
    
    
17. ZHAO X, Cao R, Tian X, Liu P, et al
    OAB-14 Attenuated Glymphatic System Disorder, Neuroinflammation and Dyskinesia in Parkinson's Disease Model Mice Induced by Rotenone.
    Neurochem Res. 2025;50:142.
    PubMed     Abstract available
    
    
    November 2024
18. KHODIR SA, Sweed EM, Faried MA, Abo Elkhair DM, et al
    Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson's Disease in Rats: The Putative Role of the JAK/STAT Pathway.
    Neurochem Res. 2024;50:30.
    PubMed     Abstract available
    
    
    
19. CHEN Y, Gu Y, Cao C, Zheng Q, et al
    Exploring alpha-synuclein Interaction Partners and their Potential Clinical Implications for Parkinson's Disease.
    Neurochem Res. 2024;50:23.
    PubMed     Abstract available
    
    
    
20. GAO Y, Li S, Zhang S, Zhang Y, et al
    Atractylenolide-I Attenuates MPTP/MPP(+)?Mediated Oxidative Stress in Parkinson's Disease Through SIRT1/PGC?1alpha/Nrf2 Axis.
    Neurochem Res. 2024;50:18.
    PubMed     Abstract available
    
    
    August 2024
21. MUHAMMAD AJ, Al-Baqami FF, Alanazi FE, Alattar A, et al
    The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson's Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2.
    Neurochem Res. 2024 Aug 27. doi: 10.1007/s11064-024-04226.
    PubMed     Abstract available
    
    
    
22. AZIZIFAR N, Mohaddes G, Keyhanmanesh R, Athari SZ, et al
    Intranasal AdipoRon Mitigated Anxiety and Depression-Like Behaviors in 6-OHDA-Induced Parkinson 's Disease Rat Model: Going Beyond Motor Symptoms.
    Neurochem Res. 2024 Aug 3. doi: 10.1007/s11064-024-04223.
    PubMed     Abstract available
    
    
    
23. PEREZ VISNUK D, LeBlanc JG, de Moreno de LeBlanc A
    Neuroprotective Effects Exerted by a Combination of Selected Lactic Acid Bacteria in a Mouse Parkinsonism Model under Levodopa-Benserazide Treatment.
    Neurochem Res. 2024 Aug 1. doi: 10.1007/s11064-024-04217.
    PubMed     Abstract available
    
    
    May 2024
24. THIRUPATHI A, Marqueze LF, Outeiro TF, Radak Z, et al
    Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson's Disease.
    Neurochem Res. 2024 May 24. doi: 10.1007/s11064-024-04152.
    PubMed     Abstract available
    
    
    April 2024
25. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Correction: Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Apr 16. doi: 10.1007/s11064-024-04138.
    PubMed    
    
    
    
26. PERLIKOWSKA R, Silva J, Alves C, Susano P, et al
    Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2.
    Neurochem Res. 2024;49:895-918.
    PubMed     Abstract available
    
    
    March 2024
27. ZHAO J, Wang J, Zhao K, Zhang Y, et al
    Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson's Disease Mice Model.
    Neurochem Res. 2024 Mar 29. doi: 10.1007/s11064-024-04132.
    PubMed     Abstract available
    
    
    
28. KRYL'SKII ED, Razuvaev GA, Popova TN, Oleinik SA, et al
    6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis.
    Neurochem Res. 2024 Mar 19. doi: 10.1007/s11064-024-04125.
    PubMed     Abstract available
    
    
    
29. ESTEVES M, Cristovao AC, Vale A, Machado-Pereira M, et al
    MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
    Neurochem Res. 2024 Mar 7. doi: 10.1007/s11064-024-04130.
    PubMed     Abstract available
    
    
    February 2024
30. SHEN J, Chen S, Li X, Wu L, et al
    Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
    Neurochem Res. 2024 Feb 29. doi: 10.1007/s11064-024-04116.
    PubMed     Abstract available
    
    
    
31. XU F, Bian N, Li X
    SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
    Neurochem Res. 2024 Feb 21. doi: 10.1007/s11064-024-04106.
    PubMed     Abstract available
    
    
    
32. YANG J, Du C, Li Y, Liu R, et al
    Contrasting Iron Metabolism in Undifferentiated Versus Differentiated MO3.13 Oligodendrocytes via IL-1beta-Induced Iron Regulatory Protein 1.
    Neurochem Res. 2024;49:466-476.
    PubMed     Abstract available
    
    
    January 2024
33. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Jan 26. doi: 10.1007/s11064-024-04099.
    PubMed     Abstract available
    
    
    
34. DE ASSIS ALC, de Araujo Rodrigues P, de Morais SM, Rodrigues ALM, et al
    Byrsonima sericea Ethanol Extract Protected PC12 Cells from the Oxidative Stress and Apoptosis Induced by 6-Hydroxydopamine.
    Neurochem Res. 2024;49:234-244.
    PubMed     Abstract available
    
    
    
35. NISHIGUCHI H, Omura T, Sato A, Kitahiro Y, et al
    Luteolin Protects Against 6-Hydoroxydopamine-Induced Cell Death via an Upregulation of HRD1 and SEL1L.
    Neurochem Res. 2024;49:117-128.
    PubMed     Abstract available
    
    
    August 2023
36. HE ZQ, Huan PF, Wang L, He JC, et al
    Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-kappaB Signaling.
    Neurochem Res. 2023 Aug 10. doi: 10.1007/s11064-023-04004.
    PubMed     Abstract available
    
    
    
37. DA CRUZ GUEDES E, Erustes AG, Leao AHFF, Carneiro CA, et al
    Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or alpha-synuclein in Caenorhabditis elegans.
    Neurochem Res. 2023;48:2390-2405.
    PubMed     Abstract available
    
    
    July 2023
38. TIWARI S, Gupta P, Singh A, Chaturvedi S, et al
    Correction to: 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.
    Neurochem Res. 2023 Jul 5. doi: 10.1007/s11064-023-03975.
    PubMed    
    
    
    May 2023
39. SIDDIQUI T, Bhatt LK
    Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease.
    Neurochem Res. 2023 May 31:1-11. doi: 10.1007/s11064-023-03960.
    PubMed     Abstract available
    
    
    
40. SHARMA M, Sharma N, Khairnar A
    Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.
    Neurochem Res. 2023;48:1543-1560.
    PubMed     Abstract available
    
    
    March 2023
41. CHITHRA Y, Dey G, Ghose V, Chandramohan V, et al
    Mitochondrial Complex I Inhibition in Dopaminergic Neurons Causes Altered Protein Profile and Protein Oxidation: Implications for Parkinson's disease.
    Neurochem Res. 2023 Mar 25. doi: 10.1007/s11064-023-03907.
    PubMed     Abstract available
    
    
    
42. MORADI VASTEGANI S, Nasrolahi A, Ghaderi S, Belali R, et al
    Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies.
    Neurochem Res. 2023 Mar 21. doi: 10.1007/s11064-023-03904.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.